Drugs & TargetsFree TESARO achieves Zejula prostate cancer development milestone by Janssen November 02, 2018Vol.44 No.41
Drugs & TargetsFree Cofactor Genomics launches ImmunoPrism kit for use in clinical sequencing laboratories November 02, 2018Vol.44 No.41
Clinical RoundupFree Survey shows 4 in 10 Americans believe alternative therapies can cure cancer November 02, 2018Vol.44 No.41
Clinical RoundupFree Study identifies factors for reducing risk of immunosuppression, fever in people treated with chemotherapy November 02, 2018Vol.44 No.41
FreeFunding Opportunities Global challenge aims to open new direction in breast cancer research November 02, 2018Vol.44 No.41
FreeIn Brief Adam Margolin to lead new $200M program to accelerate precision medicine at Mount Sinai November 02, 2018Vol.44 No.41
FreeIn Brief Andrzej Dlugosz to oversee basic science research at Rogel Cancer Center November 02, 2018Vol.44 No.41
FreeIn Brief Leonard Freedman named chief science officer at Frederick National Laboratory November 02, 2018Vol.44 No.41
FreeIn Brief Johnathan Whetstine to lead Cancer Epigenetics Program at Fox Chase November 02, 2018Vol.44 No.41
